Bioatla Valuation
| BCAB Stock | USD 0.14 0.01 4.67% |
Bioatla seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Bioatla from analyzing the firm fundamentals such as Shares Owned By Insiders of 6.78 %, return on equity of -8.14, and Current Valuation of 9.09 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bioatla's valuation include:
Price Book 2.681 | Enterprise Value | Enterprise Value Ebitda 0.3052 | Price Sales 4.2173 | Enterprise Value Revenue 2.4321 |
Undervalued
Today
Please note that Bioatla's price fluctuation is dangerous at this time. Calculation of the real value of Bioatla is based on 3 months time horizon. Increasing Bioatla's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bioatla is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioatla Stock. However, Bioatla's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.14 | Real 2.61 | Target 10.0 | Hype 0.11 |
The real value of Bioatla Stock, also known as its intrinsic value, is the underlying worth of Bioatla Company, which is reflected in its stock price. It is based on Bioatla's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bioatla's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bioatla helps investors to forecast how Bioatla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioatla more accurately as focusing exclusively on Bioatla's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bioatla's intrinsic value based on its ongoing forecasts of Bioatla's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bioatla's closest peers. If more than one evaluation category is relevant for Bioatla we suggest using both methods to arrive at a better estimate.
Bioatla Cash |
|
Bioatla Total Value Analysis
Bioatla is currently forecasted to have valuation of 9.09 M with market capitalization of 11.14 M, debt of 836 K, and cash on hands of 178.12 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bioatla fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.09 M | 11.14 M | 836 K | 178.12 M |
Bioatla Investor Information
About 30.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.15. Bioatla had not issued any dividends in recent years. Based on the key measurements obtained from Bioatla's financial statements, Bioatla is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Bioatla Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioatla has an asset utilization ratio of 20.98 percent. This suggests that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that Bioatla is more efficient with each dollar of assets it utilizes for everyday operations.Bioatla Profitability Analysis
Based on the key profitability measurements obtained from Bioatla's financial statements, Bioatla may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Bioatla's ability to earn profits and add value for shareholders.Net Loss | First Reported 2019-12-31 | Previous Quarter -18.7 M | Current Value -15.8 M | Quarterly Volatility 9.3 M |
For Bioatla profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioatla to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioatla utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioatla's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioatla over time as well as its relative position and ranking within its peers.
Bioatla Earnings per Share Projection vs Actual
By analyzing Bioatla's earnings estimates, investors can diagnose different trends across Bioatla's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Bioatla is based on EPS before non-recurring items and includes expenses related to employee stock options.Bioatla Ownership Allocation
Bioatla holds a total of 74.26 Million outstanding shares. 30% of Bioatla outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bioatla Profitability Analysis
The company reported the previous year's revenue of 11 M. Net Loss for the year was (69.78 M) with loss before overhead, payroll, taxes, and interest of (46.73 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bioatla's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bioatla and how it compares across the competition.
About Bioatla Valuation
The stock valuation mechanism determines Bioatla's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bioatla. We calculate exposure to Bioatla's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioatla's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.6 M | 12.2 M | |
| Pretax Profit Margin | (7.29) | (7.66) | |
| Operating Profit Margin | (7.73) | (8.12) | |
| Net Loss | (7.29) | (7.66) | |
| Gross Profit Margin | 1.05 | 1.11 |
Bioatla Current Valuation Indicators
Valuation refers to the process of determining the present value of Bioatla and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Bioatla we look at many different elements of the entity such as Bioatla's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bioatla, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bioatla's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bioatla's worth.Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |